This mutation causes loss of Gnaq protein function leading to, as demonstrated by increased binding to G beta-gamma protein in cell culture, high Erk and Akt phosphorylation in cultured cells and xenograft tumors, and increased tumor growth in mouse models compared to the wild-type GNAQ [44,45]. The gene discussed is AKT1; the disease is neoplasm.